PTEN and hepatocellular carcinoma: We were also committed to developing a prognostic classification model based on the heterogeneity of PTEN expression to explore its sensitivity as an indicator of HCC prognosis and immunotherapy response, which may be helpful for HCC prognosis and post-treatment monitoring.